HudsonAlpha Welcomes New Director for Clinical Services Lab

Huntsville, Ala. – The HudsonAlpha Institute for Biotechnology has named Elaine Lyon, PhD, FACMG, director of the HudsonAlpha Clinical Services Lab (CSL).

Lyon comes to HudsonAlpha from the University of Utah, where she served as medical director for molecular genetics, genomics and pharmacogenetics at the Associated Regional and University Pathologists (ARUP) Laboratories. At ARUP, she designed and validated laboratory assays for clinical use, including genomic sequencing. During her tenure, Lyon helped established four laboratory sections at ARUP: Molecular Genetics, Fragment Analysis, Genetics Sequencing and Genomics. She also held a faculty position at the University of Utah School of Medicine as professor of pathology.

Lyon brings more than 20 years of clinical genomics experience to the institute. Her national and international efforts have promoted appropriate molecular genetic clinical testing.

“I’ve been impressed with HudsonAlpha’s commitment to quality in human genomics ever since I learned of their work through the CSER (Clinical Sequencing Evidence-generating Research) program. I am delighted to join their team and work with the Clinical Services Laboratory to provide answers to patients, families and clinicians who have sought these services,” Lyon said.

Lyon received her PhD in medical genetics from the University of Alabama at Birmingham (UAB), and completed a fellowship in clinical molecular genetics at the University of Utah. She has served as president of the Association for Molecular Pathology and led the organization’s Task Force for the Framework for the Evidence Needed to Demonstrate (FEND) Clinical Utility. Lyon is also a member of the board of the American College of Medical Genetics and Genomics.

“We are thrilled to have Dr. Lyon join the CSL team,” said Shawn Levy, PhD, executive director of the CSL and faculty investigator at HudsonAlpha. “Her clinical genomics and research expertise will accelerate our mission to advance personalized patient care.”

The CSL was established in 2014 to advance the application of genomic technologies in clinical research and diagnostics. The lab offers whole genome sequencing and analysis, and is developing a number of new genetic and genomic clinical tests.

To learn more about the CSL, visit

About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha’s vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. The state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education and includes more than 30 diverse biotech companies on campus. To learn more about HudsonAlpha, visit